GSK vs SEDG · P/E 13, $103.31B cap vs rev $656.7M
GlaxoSmithKline PLC ADR (GSK) versus SolarEdge Technologies Inc (SEDG) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
SolarEdge Technologies Inc (SEDG) is a solar company listed on US. It is led by Yehoshua Nir.
GSK does not have a complete income-statement cache yet.
Latest reported SEDG revenue for 2026-06-30 was $656.7M. Net income was -$88.1M. SEDG currently screens at market cap $3.84B.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. SEDG currently screens at market cap $3.84B.
Not investment advice. Open the GSK and SEDG stock pages for the full models.
Not investment advice.